CoChat

Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease

Open access
Badimon, Lina, Bugiardini, Raffaele, Cenko, Edina, Cubedo, Judit, Dorobantu, Maria, Duncker, Dirk J., Estruch, Ramón, Milicic, Davor, Tousoulis, Dimitris, Vasiljevic, Zorana, Vilahur, Gemma, de Wit, Cor, Koller, Akos · 2017 · European Heart Journal
Cited by 88

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

The epidemic of obesity is recognized as one of the most important public health problems facing the world today. According to 2014 World Health Organization (WHO) data,1 39% of adults worldwide are overweight (body mass index, BMI ≥ 25 kg/m2) and 13% of adults are obese (BMI ≥ 30 kg/m2). Thus, more than half a billion adults worldwide are classified as obese. The prevalence of obesity varies by geographical region, gender and income level. The highest prevalence is found in the USA (61% overweight, 27% obese), closely followed by Europe (59% overweight, 23% obese), with the lowest prevalence in South–East Asia (22% overweight, and 5% obese). In Europe, the vast majority of countries have an overweight prevalence of more than 60%.1 Asians generally have a higher percentage of body fat than Caucasians of the same age, sex and BMI. Even below the usual cut-off of BMI = 25 kg/m2 Asian people seem to be at increased risk for type 2 diabetes.2 This may have implications for obesity diagnostic criteria. Indeed, the proposed optimal BMI cut-off values by WHO in Asian populations seems to vary from 22 to 25 kg/m2 based on the ethnic background. A Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian Indians has suggested the following BMI cut-off values: normal BMI = 18.0–22.9 kg/m2; overweight = 23.0–24.9 kg/m2; and obesity > 25 kg/m2.3 Thus it is indeed debatable whether uniform BMI cut-off values to diagnose obesity and/or for cardiovascular risk stratification purposes can be use worldwide. The use of additional anthropometric measurements e.g. waist-circumference or CT based quantification of abdominal/subcutaneous fat volume could help to better delineate obesity and risk parameters and to implement preventive strategies against obesity in each specific ethnic scenario. See Supplementary material online, Appendix. Obesity and overweight are risk factors for the development atherosclerosis. The adipose tissue (AT) was traditionally considered an energy storage organ. However, a large body of evidence highlights the AT as an active endocrine organ that secretes numerous hormones and bioactive molecules.4 These adipokines (or adipocytokines) can act in an endocrine, autocrine and paracrine manner regulating not only AT metabolism, but also other organs, such as liver, muscle, the central nervous system and pancreas. Thus, adipokines represent key regulators of glucose level, lipid metabolism, blood pressure, inflammation, and oxidative stress.5 Several lines of evidence point to adipokine deregulation as the link between obesity and development of cardiovascular disease (CVD).6 Various adipokines, including adiponectin, leptin, omentin, and resistin, have been implicated in modulating the atherogenic environment of the vessel wall by affecting endothelial and arterial smooth muscle cell function, as well as macrophages. Interestingly, certain AT depots show a stronger correlation with obesity-associated co-morbidities than total AT mass, reinforcing the concept of depot-specific metabolic functions.7 The principal depots of white AT (WAT) include the visceral AT (VAT), surrounding the visceral organs, the subcutaneous AT (SAT) located below the skin, and the ectopic AT which consists of non-storage depots. Although overall fat mass is important for the development of obesity-associated co-morbidities, VAT accumulation is an independent risk factor for obesity-related metabolic and CVD.8 This differential impact on cardiovascular risk seems to be related to the adipokines secreted from the different fat depots. Specifically, leptin, mainly secreted by SAT, is positively correlated with body fat whereas adiponectin which is more influenced by VAT is reduced in obesity. One particular ectopic AT depot that has attracted major attention is fat surrounding the vasculature, also known as perivascular AT (PVAT), which appears to play an essential role in the control of vascular function and remodelling.9 In lean individuals PVAT exerts vasodilatory and anti-inflammatory functions. These beneficial actions of PVAT are blunted in obesity where the pro-inflammatory state leads to insulin resistance and increased oxidative stress, thereby contributing to vascular dysfunction and remodelling.9 See Supplementary material online, Appendix. Brown AT (BAT) has a different cellular structure, metabolic profile, and function than WAT. Brown AT dissipates energy by uncoupled UCP-1-mediated respiration resulting in heat production (thermogenesis), increased fatty acid oxidation and decreased lipid storage. Brown AT in humans has been traditionally found in neonates; however, the presence of some BAT depots in human adults has also been reported.10 Initially identified in rodents, beige AT (‘brite’, ‘brown-like’, or ‘inducible brown’ AT) is an inducible form of thermogenic AT with a low UCP-1 content in basal conditions that can be induced to increase energy consumption.11 Although its

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehx181

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 23 references

Cited by

See all 88

Metadata

Authors
Badimon, L., Bugiardini, R., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Estruch, R., Milicic, D., Tousoulis, D., Vasiljevic, Z., Vilahur, G., de Wit, C., & Koller, A.
Venue
European Heart Journal
Published
2017-05-10
Volume
38
Issue
25
Pages
1951-1958
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2612075601
Cited by
88
References
23
FWCI
7.07
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease. https://app.cochat.ai/papers/10.1093/eurheartj/ehx181
The paper
Badimon, L., Bugiardini, R., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Estruch, R., Milicic, D., Tousoulis, D., Vasiljevic, Z., Vilahur, G., de Wit, C., & Koller, A. (2017). Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx181

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.